WO2005102408A2 - A telescoping perfusion management system - Google Patents

A telescoping perfusion management system Download PDF

Info

Publication number
WO2005102408A2
WO2005102408A2 PCT/US2005/013346 US2005013346W WO2005102408A2 WO 2005102408 A2 WO2005102408 A2 WO 2005102408A2 US 2005013346 W US2005013346 W US 2005013346W WO 2005102408 A2 WO2005102408 A2 WO 2005102408A2
Authority
WO
WIPO (PCT)
Prior art keywords
coupled
perfusion management
method further
flexible finger
cell
Prior art date
Application number
PCT/US2005/013346
Other languages
French (fr)
Other versions
WO2005102408A3 (en
Inventor
Jr. Lowell L. Wood
Original Assignee
Searete Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/827,576 external-priority patent/US8337482B2/en
Priority claimed from US10/827,578 external-priority patent/US20050234440A1/en
Priority claimed from US10/827,390 external-priority patent/US8361013B2/en
Application filed by Searete Llc filed Critical Searete Llc
Publication of WO2005102408A2 publication Critical patent/WO2005102408A2/en
Publication of WO2005102408A3 publication Critical patent/WO2005102408A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/076Permanent implantations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876Blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/77Suction-irrigation systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00002Operational features of endoscopes
    • A61B1/00011Operational features of endoscopes characterised by signal transmission
    • A61B1/00016Operational features of endoscopes characterised by signal transmission using wireless means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041Capsule endoscopes for imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/028Microscale sensors, e.g. electromechanical sensors [MEMS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7232Signal processing specially adapted for physiological signals or for diagnostic purposes involving compression of the physiological signal, e.g. to extend the signal recording period
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants
    • A61F2250/0002Means for transferring electromagnetic energy to implants for data transfer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3561Range local, e.g. within room or hospital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/08Supports for equipment
    • A61M2209/084Supporting bases, stands for equipment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining

Definitions

  • TECHNICAL FIELD The present application relates, in general, to detection and/or treatment
  • a system includes but is not limited to: a body portion; an extending part with a proximal end piece and a distal end piece and wherein the proximal end piece is coupled to the body portion; at least one receiving body in communication with the extending part; and a control circuit coupled to the receiving unit or the extending part.
  • a method includes but is not limited to: forming a hollow part for storing a receivable; coupling a flexible finger to the hollow part and configuring the flexible finger for extending from the hollow part to a location in an animal; and coupling the flexible finger to the hollow portion and to a control system including logic or software operable for delivering the receivable from the hollow part to the location in the animal.
  • a method includes but is not limited to: storing a receivable in a cavity; extending a tractable conduit between the cavity and a location in an animal; and delivering the receivable to the location in the animal.
  • related systems include but are not limited to circuitry and/or programming for effecting the herein-referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein- referenced method aspects depending upon the design choices of the system- designer.
  • FIGURE 1 is a front-plan view of a telescoping perfusion management device 100.
  • Figure 2 is a front plan view of one aspect of the telescoping perfusion management device 100.
  • Figure 3 is an exploded view of an extending part of the telescoping perfusion management devicelOO.
  • Figure 4 is a cross section view of the extended part of the telescoping perfusion management devicelOO.
  • Figure 5 is diagrammatic view of the control circuit 210.
  • Figure 6 illustrates an example wherein the telescoping perfusion management device 100 is placed in a location in a human body 501 and the extended part directed to a new location in the human body.
  • FIG. 1 shown is a front plan view illustrative of various exemplary perfusion management device(s) and/or process(es). Accordingly, the present application first describes certain specific exemplary structures of Figure 1; thereafter, the present application illustrates certain specific exemplary processes. Those having skill in the art will appreciate that the specific devices and processes described herein are intended as merely illustrative of their more general counterparts.
  • FIG. 1 shown is a front-plan view of a telescoping perfusion management device 100.
  • At least one extended part 104 projects from a body portion 102.
  • the extended part 104 is coupled to the body portion 102 by a proximal end piece 103.
  • Fluid may be delivered to a location by one or more apertures included in a distal end piece 105 of the extended part 104.
  • At least one receiving body 206 within the body portion 102 contains a fluid, for example, a fluid for treatment.
  • a controllable valve 208 provides a
  • a control circuit 210 provides a control signal that may open or close the control valve 208.
  • each one of the extended part 104 of the multiple extended parts is on fluid communication with the receiving body 206 and a control valve 208.
  • a sense line 214 connects the control circuit 210 to the sensor 316 at the distal end of each of the extended part 104.
  • the control circuit 210 may be connected to a sense line 214 that allows it to monitor the fluid levels within the at least one receiving body 206.
  • the extended part 104 includes a plurality of sliding pieces, for example, inwardly stiding pieces or outwardly sliding pieces.
  • a proximal end of one sliding piece slides into a distal end of an adjacent proximal sliding piece.
  • the diameter of the plurality of sliding pieces may for example, be uniform, increasing or decreasing.
  • the diameter, the size or dimensions of the plurality of sliding pieces is dependant on the size of the lumen being traveled by the extended part 104.
  • the lumen of a blood vessel may have a two-fold decrease in diameter.
  • the extended part 104 designed to travel such a blood vessel, may have at least a two-fold decrease in the diameter of the plurality of each of the sliding pieces.
  • the extended part 104 telescopes and snakes or travels through the lumen of a vessel to a target location in an animal.
  • the extended part 104 is made of eight inwardly sliding pieces.
  • sliding piece 1 is coupled to the body portion 102 and sliding piece 8 represents the distal sliding part.
  • the length of each siding piece LI, L2, L3, L4, L5 L6 L7 L8 decreases two-fold while the corresponding diameter Dl, D2, D3, D4, D5, D6, D7 AND D8 also decreases twofold.
  • the exemplary embodiment of Figure 4 includes twofold variations between lengths and diameters of subsequent pieces, and such
  • a Telescoping Perfusion Management System variation may correspond to relative dimensions of blood vessels in the human body, other ratios may be desirable in some applications.
  • ratios of dimensions, either length, diameter or both of sequential pieces may vary according to the structure to be treated or examined.
  • each of the extended part 104 of the multiple extended parts is in fluid communication with at least one of a respective receiving body 206 filled with a different fluid for delivery.
  • the at least one receiving body 206 maybe coupled to a mixing chamber where the fluid contents of the at least one receiving body 206 are present for mixing and the mixed contents enter the extended part 104 for delivery to a selected location.
  • the choice of the fluid in the at least one receiving body 106 may depend, for example, on the purpose of the device, for example, treatment of colon cancer, treatment of breast cancer, or treatment of an arterial disease.
  • the choice of fluid in the receiving body 106 includes, but is not limited to, for example, a chemical, a chemical compound, a protein, a lipoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger a molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction.
  • the receiving body 106 may also be utilized for storage and disposal of operational fluids.
  • fluid-like substances such as gels
  • fluidizable substances or non-fluid type substances such as small solid particles
  • the nature of the fluid in the receiving body 206 includes, for example, and is not limited to, a liquid, a solution, a mixture, a gel, a colloid, a colloid of a suitable viscosity, a suspension, an emulsion, or any material of low shear-strength for delivery to a site.
  • one or more fluids are delivered to one or more of selected locations by the telescoping perfusion management device 100.
  • the selected location
  • a Telescor-ing Perfusion Management System may be, for example, in proximity to or within a tumor, a circulatory system, an aorta, a vena cava, a site of therapy, or a site of investigation in an animal.
  • a pump 218 provides fluid at a controlled flow rate for delivery to a site from the receiving body 106.
  • the type of pump is not critical to the invention and may include, for example, a mechanical pump, a piezoelectric pump, an osmotic pump, a source of pressure, or a device for maint ning a positive flow of fluid through the device.
  • fluid flow may be further modulated with micro valves and/or self- pressurizing fiuidic receiving bodies.
  • the fluid may be delivered without a pump.
  • fluid delivery may be controlled using a pressurized bladder, controlled dissolution or dilution of a material, a drip or gravity type of approach, or any other suitable approach to deliver the appropriate amount or an appropriate delivery-rate of the fluid.
  • the telescoping perfusion management device 100 includes an electroactive polymer performing thermodynamic functions and providing the driving force for moving a fluid.
  • the electroactive polymer may be in fluid communication with a receivable present in the receiving body 206. Deflection of the electroactive polymer may provide the force needed to move the receivable through the extended part 104. The deflection of the electroactive polymer may result, for example, when an electrical field is applied to the electroactive polymer.
  • the telescoping device for perfusion management 100 may include one or more electroactive polymers.
  • the electro active polymer is included in one or more transducers.
  • the electroactive polymer is in electrical communication with electrodes present in the transducer and is arranged such that the deflection of the electroactive polymer transmits a motion to the fluid.
  • electroactive polymers may be part of an actuator.
  • the electroactive polymer may be, for example, a gel, a solid or a liquid. Additional information can be found, for example, in US patent number 6,249,076 to Madden, et. al, entitled CONDUCTING POLYMER ACTUATOR and published US
  • the senor 316 is an array of sensors, deployed from one or more portholes, at the distal end of each of the sliding parts.
  • the portholes are sized and shaped to provide access through which the sensors 316 may be deployed.
  • the portholes may include seals, stress relief or other features appropriate for proper mechanical deployment.
  • one or more of the portholes can be controllably opened or closed to provide communication exterior to the extended part or main body.
  • the sensor 316 may be retracted within the port hole and deployed through the porthole.
  • the array of sensors may include, but is not limited to, for example, sensors for detecting pressure, temperature, chemical, gas, electrolyte, flow, volume, composition, or concentration.
  • microelectrodes such as, for example, solid-state microlectrodes are sensitized with an agent for detecting a relevant interactor. Examples of the agent include, but are not limited to, for example, agonists of angiogenesis.
  • the choice of sensor 316 depends on the physiological variable being monitored, treated, or controlled.
  • physiological variable refers to any and all measurements relating to the functioning of a living organism under normal, sub-normal, or abnormal states.
  • an operative tool 324 is coupled to the distal most sliding part of the extended part 105, or deployed from the porthole, or carried by the extended part 104, further including a carrying line in communication with the control circuit 210.
  • the operative tool 324 includes, but is not limited to, for example, one or more of a combination of, a tool positioner, an ablation device, a laser, a vacuum, a siphon 326, an evacuation device, a fluid dispenser 328, a
  • the vacuum or the siphon is employed for removing a cell, a mass of cells, a tissue, a fluid, a gel, a sample, debris, a contaminant, or other material for which removal is desired or appropriate.
  • the ablation device operates for perturbing or reducing the structural integrity or viability of a cell, a mass of cells, an assembly of biological materials exhibiting shear strength, or a tissue.
  • the assembly of biological materials includes, for example, blood clots, cartilage, or bone.
  • the source of an electric or electromagnetic charge 422 includes, but is not limited to, for example, steady state electric currents, time-varying electric currents, pulsed currents, radio waves, microwaves, ultraviolet energy, infra-red energy, optical energy, terahertz beams, or the like or any combination thereof.
  • the operative tool 324 may include a set of devices having general or "multipurpose" utility.
  • the operative tool 324 may include, but is not limited to, for example, a combination of the fluid dispenser 328, the siphon 326, and the ablation device.
  • the operative tool combination for example, delivers the fluid or gel, ablates cells, and removes debris.
  • the plurality of sliding parts may themselves be hollow fonning a conduit for delivery of the fluid to a site, or for housing a circuitry coupling the control circuit 210 to the operative tool 324, or for housing a mechanism that guides the extended part 104 or the plurality of sliding parts.
  • the device for perfusion management 100 shows a data transmitter 410, and a data receiver 408 coupled to the control circuit 210.
  • An antenna 412 may be used for transmitting data to the exterior wirelessly.
  • the antenna 412 is shown diagrammatically, but may be a structure, such as a strip antenna, that may be integrated in a manner that does not impair or significantly perturb system performance.
  • the control circuit 210 is depicted as having a
  • a Telescoping Perfusion Management System processor 402 coupled to a memory 404 that provides data storage and retrieval capability, and a power source 406.
  • Feedback circuitry or logic circuitry provides communication between the control circuit 210 and devices in communication with it.
  • a software program providing instructions may be stored in the memory 404 to control operation of the control circuitry or to store data gathered under control of the control circuitry.
  • the control circuit 210 may have components for system integrated digital data gathering, processing, storage, compression and transmission. These can provide data control capabilities and operation control capabilities.
  • the transmission components may communicate through the antenna 412 to a person, system, computer, or device exterior to the body. This communication can allow data gathered by the sensors to be displayed, stored or otherwise processed in the external environment.
  • this connnunication may allow for the processed data or a plurality of new data to be received from the exterior by the device for perfusion management 100.
  • Data compression can allow the control circuitry to store data representing larger amounts of data to be stored in the memory 404 or to be transmitted to the exterior environment in a more efficient manner.
  • one or more of the operative tools 324 are mounted on an actuator 414 which allows for the independent movement of each tool.
  • one or more operative tools 324 may be mounted as a unit on one actuator 414 and moved as a group, for example, forming an aspirating-dispensing unit.
  • the fluid dispenser 328 and the siphon 326 may be mounted together as a group.
  • the actuator 414 may be a motor, a piezo electrically driven actuator, a micromechanical or electrical effector, shape memory actuators, electroactive polymer actuators, or the like.
  • the extended part 104 may include an imaging device deployed from the porthole or from the distal end of the extended part 104 or carried by a carrying line.
  • imaging device being used herein to designate in general those components, circuits, assemblies and sub-assemblies comprising electrical, optical, or opto-electronic components.
  • the control circuit 210 is coupled
  • a Telescoping Perfusion Management System to the imaging device that includes a laser 418, or a source of light or scene-illuminating radiation, coupled to an optical feed line 420 to illuminate an area.
  • a charge coupled device is positioned to capture data from the illuminated area and provides an electronic signal indicative of the area imaged.
  • Conventional circuitry then produces a digital representation that may be displayed, stored in the memory 404, or otherwise processed.
  • the displayed image may serve, for example, for guiding the extended part 104 to the selected location or for determining the efficacy of a treatment or a procedure.
  • the imaging device described herein is exemplary of imaging devices and that other imaging devices, including for example, raster and line- scanning imagers, nonvisible spectral imagers, and fluorescence imagers, may be included.
  • the telescoping perfusion management device 100 is depicted implanted in an abdominal aorta 602 with the extended part 104 traveling a blood vessel in a human body.
  • the device for perfusion management 100 is configured for full or partial placement in the human body.
  • the configuration may incorporate a combination of the following criteria, including but not limited to, dimensions, composition, shape, power dissipation level, or texture.
  • the body portion 102 is sized for implantation in proximity to the aorta 602 or the vena cava and the extended part 104 is sized for traveling a blood vessel in an animal, for example, the human body.
  • each of the sliding pieces has about a two-fold decrease in diameter.
  • the length of the extended part 104 depends upon the distance between the selected location and the location of the body portion 102, and the route traveled by the extended part 104 to arrive at the selected location. It will be appreciated by those having skill in the art that the extended part 104 including the one or more of the operative tools 324 is of a size, dimension or shape operable for traveling one or more blood vessel of decreasing or increasing luminal diameter.
  • the extended part 104 and the one or more operative tool 324 may pass through the wall of the lumen, or fr-ms-luminally, to the surrounding tissue for detecting, delivery of a treatment, or for sampling. It will also be appreciated by those having skill in the art that the frans-luminal
  • a Telescoping Perfusion Management System mode described is not limited to blood vessels and includes the space or cavity of an organ or structure.
  • the telescoping perfusion management devicelOO and its components may have a size, dimension, shape, material, and properties of flexion, retraction, and extension to allow for the steering, guiding, or positioning of the components of the telescoping perfusion management device 100.
  • the extended part 104 may need to be steered around an occlusion or a fork in the vasculature.
  • the extended part 104 may need to be retracted, repositioned and then extended in a new direction.
  • Extending, retracting or repositioning of the extended part 104 may be accomplished by techniques known in the art, for example, by using a guide wire or a by employing an active polymer.
  • the extended part may be retracted and then "punched through" an occlusion to dislodge it.
  • lasers, shears, or a drug maybe employed to degrade the occlusion.
  • the siphon 326 or an evacuation device is employed to evacuate any debris, before the extended part 104 continues traveling the circulatory system.
  • the telescoping perfusion management device 100 is not restricted to traveling the circulatory system but may be implanted in any tissue, such as, for example, nerve, epithelial, dermal, sub-dermal, connective, or muscle tissue. Additionally, the telescoping perfusion management device 100 may be implanted in inter-tissue spaces, or inter-organ spaces, for example, those found wii-hin a body cavity.
  • the telescoping perfusion management device 100 includes an array of sensors 316 positioned across the plurahty of sliding parts 304 for monitoring, tracking, or mapping a gradient of temperature, pressure, flow, or material concentration in one or more locations.
  • the one or more location may be, for example, a tissue, an artery, or a vein.
  • the device for perfusion management 100 has an auto- correct feature for correcting a sub-normal or abnormal gradient of temperature, pressure, flow concentration, or material concentration
  • the telescoping perfusion management device 100 may be composed of materials known in the art, for example, a metal, a ceramic, a glass, a plastic, a polymer, a biologically compatible material, or a combination.
  • the telescoping perfusion management device 100 may be made of helically-coiled stainless steel wire and coated with a polymer, such as, TeflonTM.
  • the telescoping perfusion management device 100 maybe made of helically-coiled stainless steel wire and coated with a polymer and impregnated with one or more of a biological material, for example, including but not limited to, anti coagulants, or inhibitors.
  • the telescoping perfusion management device 100 is placed in proximity to the location on the animal, for example, the human body, and the extended part 104 directed to the selected location and an effective agent delivered in proximity to the selected location.
  • the extended part 104 may be retracted after such a delivery, leaving the telescoping perfusion management device 100 in place at the location, until time for a future delivery of the effective agent or another operation.
  • the majority of the telescoping perfusion management device 100 is ex vivo while the extended part 104 alternates between ex vivo and in vivo states.
  • the telescoping perfusion management device 100 is placed in proximity to the location within the animal, for example, the human body, and the extended part 104 directed to a selected location and an effective agent delivered in proximity to the selected location.
  • the extended part 104 may be retracted after such a delivery, leaving the telescoping perfusion management device 100 in place at the location, until time for a future delivery
  • a Telescoping Perfusion Management System or another operation.
  • the majority of the telescoping perfusion management devicelOO is in- vivo while the extended part 104 alternates between retracted, partially retracted or unretracted states.
  • the telescoping perfusion management device 100 is operable by a person.
  • the person monitors, guides, positions, and performs other actions/operations or manages a response consistent with the telescoping perfusion management device 100 being managed by the person.
  • a separate display device can present imagery to aid the person.
  • the imagery may be captured as described above with reference to Figure 5, may be computer generated or may be captured by a separate imaging device internal to or external to the animal ⁇ for example, the human body. Actions may be performed under control of the person who may be on site or may be linked from a remote location, or the telescoping perfusion management devicelOO may be programmed to perform some or all functions automatically.
  • the telescoping perfusion management device 100 may be programmed to perform functions, such as, lumen clearance, lumen maintenance, monitoring of concentrations, sending of alerts, delivery of one or more of the effective agent at timed intervals or locations, self-check, and self-diagnosis. It will be appreciated by those of skill in the art that the telescoping perfusion management device 100 may be programmed for complete automatic operation of one or more functions.
  • the telescoping perfusion management devicelOO need not be limited to managing perfus n.
  • the device provides a mechanism for exploring one or more regions and/or reaching a location within an animal, obtaining information, cor-maunicating this information, performing operations, performing procedures, and providing treatment.
  • a Telescoping Perfusion Management System 100 may find utility in the management of physiological functions, the detection or elimination of pathological functions or conditions, and/or treatment of diseases of non- human animals. Other modifications of the subject matter herein will be appreciated by one of skill in the art in light of the teachings herein.
  • any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionaUty is achieved, irrespective of architectures or intermedia! components.
  • any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality.

Abstract

A system (100) for perfusion management that monitors, maintains, diagnoses, or treats perfusion deficiencies.

Description

A TELESCOPING PERFUSION MANAGEMENT SYSTEM
CROSS-REFERENCE TO RELATED APPLICATIONS The present application is related to, claims the earliest available effective filing date(s) from (e.g., claims earliest available priority dates for other than provisional patent applications; claims benefits under 35 USC § 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed applications; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the following listed applications:
1. United States patent application entitled A SYSTEM FOR PERFUSION MANAGEMENT, naming Lowell L. Wood Jr. as inventor, filed substantially contemporaneously and commonly assigned herewith.
2. 'United States patent application entitled A SYSTEM WITH A SENSOR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood Jr. as inventor, filed substantially contemporaneously and commonly assigned herewith.
3. United States patent application entitled A SYSTEM WITH A RESERVOIR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood Jr. as inventor, filed substantially contemporaneously and commonly assigned herewith.
TECHNICAL FIELD The present application relates, in general, to detection and/or treatment
SUMMARY
Application Title: A Telescoping Perfusion Management System In one aspect, a system includes but is not limited to: a body portion; an extending part with a proximal end piece and a distal end piece and wherein the proximal end piece is coupled to the body portion; at least one receiving body in communication with the extending part; and a control circuit coupled to the receiving unit or the extending part. In addition to the foregoing, other method aspects are described in the claims, drawings, and text foπning a part of the present application.
In one aspect, a method includes but is not limited to: forming a hollow part for storing a receivable; coupling a flexible finger to the hollow part and configuring the flexible finger for extending from the hollow part to a location in an animal; and coupling the flexible finger to the hollow portion and to a control system including logic or software operable for delivering the receivable from the hollow part to the location in the animal. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.
In another aspect, a method includes but is not limited to: storing a receivable in a cavity; extending a tractable conduit between the cavity and a location in an animal; and delivering the receivable to the location in the animal. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.
In one or more various aspects, related systems include but are not limited to circuitry and/or programming for effecting the herein-referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein- referenced method aspects depending upon the design choices of the system- designer.
In addition to the foregoing, various other method and or system aspects are set forth and described in the text (e.g., claims and/or detailed description) and/or drawings of the present application.
Application Title: A Telescoping Perfusion Management System The foregoing is a summary and thus contains, by necessity; simplifications, generalizations and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, inventive features, and advantages of the devices and/or processes described herein, as defined solely by the claims, will become apparent in the non-limiting detailed description set forth herein.
BRIEF DESCRIPTION OF THE FIGURES Figure 1 is a front-plan view of a telescoping perfusion management device 100.
Figure 2 is a front plan view of one aspect of the telescoping perfusion management device 100.
Figure 3 is an exploded view of an extending part of the telescoping perfusion management devicelOO.
Figure 4 is a cross section view of the extended part of the telescoping perfusion management devicelOO.
Figure 5 is diagrammatic view of the control circuit 210.
Figure 6 illustrates an example wherein the telescoping perfusion management device 100 is placed in a location in a human body 501 and the extended part directed to a new location in the human body.
The use of the same symbols in different drawings typically indicates similar or identical items.
Application Title: A Telescoping Perfusion Management System DETAILED DESCRIPTION The present application uses formal outline headings for clarity of presentation. However, it is to be understood that the outline headings are for presentation purposes, and that different types of subject matter may be discussed throughout the application (e.g., device(s)/structure(s) may be described under the process(es)/operations heading(s) and/or process(es)/operations may be discussed under structure(s)/process(es) headings). Hence, the use of the formal outline headings is not intended to be in any way limiting.
1. Perfusion Management Device(s) and/or Process(es) .
With reference now to Figure 1, shown is a front plan view illustrative of various exemplary perfusion management device(s) and/or process(es). Accordingly, the present application first describes certain specific exemplary structures of Figure 1; thereafter, the present application illustrates certain specific exemplary processes. Those having skill in the art will appreciate that the specific devices and processes described herein are intended as merely illustrative of their more general counterparts.
A. Structure(s) and or Device(s)
With reference to the figures, and with reference now to Figure 1, shown is a front-plan view of a telescoping perfusion management device 100. At least one extended part 104 projects from a body portion 102. The extended part 104 is coupled to the body portion 102 by a proximal end piece 103. Fluid may be delivered to a location by one or more apertures included in a distal end piece 105 of the extended part 104.
With reference now to Figure 2, shown is an aspect of the telescoping perfusion management device 100. At least one receiving body 206 within the body portion 102 contains a fluid, for example, a fluid for treatment. A controllable valve 208 provides a
Application Title: A Telescoping Perfusion Management System path through which the fluid may travel to the at least one extended part 104. A control circuit 210 provides a control signal that may open or close the control valve 208.
With reference now to Figure 3, and continuing to refer to Figure 2, depicted is an aspect of the telescoping perfusion management device 100 which includes a body portion 102 from which multiple extended parts 104 project. In one aspect, each one of the extended part 104 of the multiple extended parts is on fluid communication with the receiving body 206 and a control valve 208. Additionally, a sense line 214 connects the control circuit 210 to the sensor 316 at the distal end of each of the extended part 104. The control circuit 210 may be connected to a sense line 214 that allows it to monitor the fluid levels within the at least one receiving body 206.
Continuing to refer to Figure 3, in one aspect, the extended part 104 includes a plurality of sliding pieces, for example, inwardly stiding pieces or outwardly sliding pieces. In one approach, a proximal end of one sliding piece slides into a distal end of an adjacent proximal sliding piece. The diameter of the plurality of sliding pieces may for example, be uniform, increasing or decreasing. The diameter, the size or dimensions of the plurality of sliding pieces is dependant on the size of the lumen being traveled by the extended part 104. For example, the lumen of a blood vessel may have a two-fold decrease in diameter. In this instance, the extended part 104, designed to travel such a blood vessel, may have at least a two-fold decrease in the diameter of the plurality of each of the sliding pieces. The extended part 104 telescopes and snakes or travels through the lumen of a vessel to a target location in an animal.
With reference now to Figure 4, and continuing to refer to Figure 3, in one approach, the extended part 104 is made of eight inwardly sliding pieces. In this aspect, sliding piece 1 is coupled to the body portion 102 and sliding piece 8 represents the distal sliding part. In this aspect the length of each siding piece LI, L2, L3, L4, L5 L6 L7 L8 decreases two-fold while the corresponding diameter Dl, D2, D3, D4, D5, D6, D7 AND D8 also decreases twofold. While the exemplary embodiment of Figure 4 includes twofold variations between lengths and diameters of subsequent pieces, and such
Application Title: A Telescoping Perfusion Management System variation may correspond to relative dimensions of blood vessels in the human body, other ratios may be desirable in some applications. For example, in some applications, ratios of dimensions, either length, diameter or both of sequential pieces may vary according to the structure to be treated or examined.
Continuing to refer to Figure 2, in one aspect, each of the extended part 104 of the multiple extended parts is in fluid communication with at least one of a respective receiving body 206 filled with a different fluid for delivery. In another approach, the at least one receiving body 206 maybe coupled to a mixing chamber where the fluid contents of the at least one receiving body 206 are present for mixing and the mixed contents enter the extended part 104 for delivery to a selected location. The choice of the fluid in the at least one receiving body 106 may depend, for example, on the purpose of the device, for example, treatment of colon cancer, treatment of breast cancer, or treatment of an arterial disease. The choice of fluid in the receiving body 106 includes, but is not limited to, for example, a chemical, a chemical compound, a protein, a lipoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger a molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction. The receiving body 106 may also be utilized for storage and disposal of operational fluids. Also, although the exemplary embodiment described herein focuses primarily on fluid delivery, one skilled in the art will understand that fluid-like substances, such as gels, and fluidizable substances or non-fluid type substances, such as small solid particles, may be delivered in accordance with the invention. It will also be appreciated by those having skill in the art that the nature of the fluid in the receiving body 206 includes, for example, and is not limited to, a liquid, a solution, a mixture, a gel, a colloid, a colloid of a suitable viscosity, a suspension, an emulsion, or any material of low shear-strength for delivery to a site.
In one aspect, one or more fluids are delivered to one or more of selected locations by the telescoping perfusion management device 100. The selected location
Application Title: A Telescor-ing Perfusion Management System may be, for example, in proximity to or within a tumor, a circulatory system, an aorta, a vena cava, a site of therapy, or a site of investigation in an animal.
Continuing to refer to Figure 2, a pump 218 provides fluid at a controlled flow rate for delivery to a site from the receiving body 106. It will be appreciated by those skilled in the art that the type of pump is not critical to the invention and may include, for example, a mechanical pump, a piezoelectric pump, an osmotic pump, a source of pressure, or a device for maint ning a positive flow of fluid through the device. Additionally, fluid flow may be further modulated with micro valves and/or self- pressurizing fiuidic receiving bodies. Moreover, in some applications, the fluid may be delivered without a pump. For example, fluid delivery may be controlled using a pressurized bladder, controlled dissolution or dilution of a material, a drip or gravity type of approach, or any other suitable approach to deliver the appropriate amount or an appropriate delivery-rate of the fluid.
Continuing to refer to Figure 2, in one aspect, the telescoping perfusion management device 100 includes an electroactive polymer performing thermodynamic functions and providing the driving force for moving a fluid. In this approach the electroactive polymer may be in fluid communication with a receivable present in the receiving body 206. Deflection of the electroactive polymer may provide the force needed to move the receivable through the extended part 104. The deflection of the electroactive polymer may result, for example, when an electrical field is applied to the electroactive polymer. In another aspect, the telescoping device for perfusion management 100 may include one or more electroactive polymers. In yet another aspect, the electro active polymer is included in one or more transducers. In this example, the electroactive polymer is in electrical communication with electrodes present in the transducer and is arranged such that the deflection of the electroactive polymer transmits a motion to the fluid. In yet another aspect, electroactive polymers may be part of an actuator. The electroactive polymer may be, for example, a gel, a solid or a liquid. Additional information can be found, for example, in US patent number 6,249,076 to Madden, et. al, entitled CONDUCTING POLYMER ACTUATOR and published US
Application Title: A Telescoping Perfusion Management System patent applications numbers 20040008853 to Perline, et al., entitled ELECTROACTIVE POLYMER DEVICES FOR MOVING FLUID and 20030069475 to Banik, et al., entitled ROBOTIC ENDOSCOPE WITH WIRELESS INTERFACE, all of which are hereby incorporated by reference in their entirety.
With reference now to Figure 3, depicted is an exploded view of the extended part 104 showing a plurality sliding parts with the sensor 316 at the distal end of each of the sliding parts. In one aspect, the sensor 316 is an array of sensors, deployed from one or more portholes, at the distal end of each of the sliding parts. In one approach, the portholes are sized and shaped to provide access through which the sensors 316 may be deployed. The portholes may include seals, stress relief or other features appropriate for proper mechanical deployment. In one approach, one or more of the portholes can be controllably opened or closed to provide communication exterior to the extended part or main body. The sensor 316 may be retracted within the port hole and deployed through the porthole. Where the porthole can be opened and closed, the porthole can close to limit communication and can be opened for deployment. The array of sensors may include, but is not limited to, for example, sensors for detecting pressure, temperature, chemical, gas, electrolyte, flow, volume, composition, or concentration. In an alternate aspect of the invention, microelectrodes, such as, for example, solid-state microlectrodes are sensitized with an agent for detecting a relevant interactor. Examples of the agent include, but are not limited to, for example, agonists of angiogenesis. The choice of sensor 316 depends on the physiological variable being monitored, treated, or controlled. The term "physiological variable" refers to any and all measurements relating to the functioning of a living organism under normal, sub-normal, or abnormal states.
Continuing to refer to Figure 3 and referring now to Figure 4, an operative tool 324 is coupled to the distal most sliding part of the extended part 105, or deployed from the porthole, or carried by the extended part 104, further including a carrying line in communication with the control circuit 210. The operative tool 324 includes, but is not limited to, for example, one or more of a combination of, a tool positioner, an ablation device, a laser, a vacuum, a siphon 326, an evacuation device, a fluid dispenser 328, a
Application Title: A Telescoping Perfusion Management System cauterizer 330, a stent 332, a tissue-liquefying device, or a source of an electric or an electromagnetic charge 422. The vacuum or the siphon is employed for removing a cell, a mass of cells, a tissue, a fluid, a gel, a sample, debris, a contaminant, or other material for which removal is desired or appropriate. The ablation device operates for perturbing or reducing the structural integrity or viability of a cell, a mass of cells, an assembly of biological materials exhibiting shear strength, or a tissue. The assembly of biological materials includes, for example, blood clots, cartilage, or bone. The source of an electric or electromagnetic charge 422 includes, but is not limited to, for example, steady state electric currents, time-varying electric currents, pulsed currents, radio waves, microwaves, ultraviolet energy, infra-red energy, optical energy, terahertz beams, or the like or any combination thereof.
Continuing to refer to Figure 3, it will be appreciated by those having skill in the art at the operative tool 324 may include a set of devices having general or "multipurpose" utility. The operative tool 324 may include, but is not limited to, for example, a combination of the fluid dispenser 328, the siphon 326, and the ablation device. In this example the operative tool combination, for example, delivers the fluid or gel, ablates cells, and removes debris.
Continuing to refer to Figure 3, the plurality of sliding parts may themselves be hollow fonning a conduit for delivery of the fluid to a site, or for housing a circuitry coupling the control circuit 210 to the operative tool 324, or for housing a mechanism that guides the extended part 104 or the plurality of sliding parts.
With reference now to Figure 5, illustrated is a schematic view of the control circuit 210 and devices in communication with the control circuit 210. The device for perfusion management 100 shows a data transmitter 410, and a data receiver 408 coupled to the control circuit 210. An antenna 412 may be used for transmitting data to the exterior wirelessly. The antenna 412 is shown diagrammatically, but may be a structure, such as a strip antenna, that may be integrated in a manner that does not impair or significantly perturb system performance. The control circuit 210 is depicted as having a
Application Title: A Telescoping Perfusion Management System processor 402 coupled to a memory 404 that provides data storage and retrieval capability, and a power source 406. Feedback circuitry or logic circuitry provides communication between the control circuit 210 and devices in communication with it. In some applications, a software program providing instructions may be stored in the memory 404 to control operation of the control circuitry or to store data gathered under control of the control circuitry. Additionally, the control circuit 210 may have components for system integrated digital data gathering, processing, storage, compression and transmission. These can provide data control capabilities and operation control capabilities. For example, the transmission components may communicate through the antenna 412 to a person, system, computer, or device exterior to the body. This communication can allow data gathered by the sensors to be displayed, stored or otherwise processed in the external environment. Additionally, this connnunication may allow for the processed data or a plurality of new data to be received from the exterior by the device for perfusion management 100. Data compression can allow the control circuitry to store data representing larger amounts of data to be stored in the memory 404 or to be transmitted to the exterior environment in a more efficient manner.
Continuing to refer to Figure 4, one or more of the operative tools 324 are mounted on an actuator 414 which allows for the independent movement of each tool. Alternatively, one or more operative tools 324 may be mounted as a unit on one actuator 414 and moved as a group, for example, forming an aspirating-dispensing unit. For example, the fluid dispenser 328 and the siphon 326 may be mounted together as a group. The actuator 414 may be a motor, a piezo electrically driven actuator, a micromechanical or electrical effector, shape memory actuators, electroactive polymer actuators, or the like.
Continuing to refer to Figure 4, the extended part 104 may include an imaging device deployed from the porthole or from the distal end of the extended part 104 or carried by a carrying line. The term "imaging device" being used herein to designate in general those components, circuits, assemblies and sub-assemblies comprising electrical, optical, or opto-electronic components. In one aspect, the control circuit 210 is coupled
Application Title: A Telescoping Perfusion Management System to the imaging device that includes a laser 418, or a source of light or scene-illuminating radiation, coupled to an optical feed line 420 to illuminate an area. A charge coupled device is positioned to capture data from the illuminated area and provides an electronic signal indicative of the area imaged. Conventional circuitry then produces a digital representation that may be displayed, stored in the memory 404, or otherwise processed. The displayed image may serve, for example, for guiding the extended part 104 to the selected location or for determining the efficacy of a treatment or a procedure. One skilled in the art will recognize that the imaging device described herein is exemplary of imaging devices and that other imaging devices, including for example, raster and line- scanning imagers, nonvisible spectral imagers, and fluorescence imagers, may be included.
With reference now to Figure 6, the telescoping perfusion management device 100 is depicted implanted in an abdominal aorta 602 with the extended part 104 traveling a blood vessel in a human body. Additionally, the device for perfusion management 100 is configured for full or partial placement in the human body. The configuration may incorporate a combination of the following criteria, including but not limited to, dimensions, composition, shape, power dissipation level, or texture. In one aspect, the body portion 102 is sized for implantation in proximity to the aorta 602 or the vena cava and the extended part 104 is sized for traveling a blood vessel in an animal, for example, the human body. In this aspect, if the vasculature decreases two-fold, each of the sliding pieces has about a two-fold decrease in diameter. The length of the extended part 104, for example, depends upon the distance between the selected location and the location of the body portion 102, and the route traveled by the extended part 104 to arrive at the selected location. It will be appreciated by those having skill in the art that the extended part 104 including the one or more of the operative tools 324 is of a size, dimension or shape operable for traveling one or more blood vessel of decreasing or increasing luminal diameter. It will also be appreciated by those having skill in the art that the extended part 104 and the one or more operative tool 324 may pass through the wall of the lumen, or fr-ms-luminally, to the surrounding tissue for detecting, delivery of a treatment, or for sampling. It will also be appreciated by those having skill in the art that the frans-luminal
Application Title: A Telescoping Perfusion Management System mode described is not limited to blood vessels and includes the space or cavity of an organ or structure.
The telescoping perfusion management devicelOO and its components, such as, for example, the extended part 104, the plurahty of sliding parts, or one or more operative tools 324, may have a size, dimension, shape, material, and properties of flexion, retraction, and extension to allow for the steering, guiding, or positioning of the components of the telescoping perfusion management device 100. For example, the extended part 104 may need to be steered around an occlusion or a fork in the vasculature. In this example, the extended part 104 may need to be retracted, repositioned and then extended in a new direction. Extending, retracting or repositioning of the extended part 104 may be accomplished by techniques known in the art, for example, by using a guide wire or a by employing an active polymer. In another aspect, the extended part may be retracted and then "punched through" an occlusion to dislodge it. In this example, lasers, shears, or a drug maybe employed to degrade the occlusion. In this example, subsequent to the dislodgement and degradation of the occlusion, the siphon 326 or an evacuation device is employed to evacuate any debris, before the extended part 104 continues traveling the circulatory system. It will also be appreciated by those skilled in the art that the telescoping perfusion management device 100 is not restricted to traveling the circulatory system but may be implanted in any tissue, such as, for example, nerve, epithelial, dermal, sub-dermal, connective, or muscle tissue. Additionally, the telescoping perfusion management device 100 may be implanted in inter-tissue spaces, or inter-organ spaces, for example, those found wii-hin a body cavity.
In one aspect the telescoping perfusion management device 100 includes an array of sensors 316 positioned across the plurahty of sliding parts 304 for monitoring, tracking, or mapping a gradient of temperature, pressure, flow, or material concentration in one or more locations. The one or more location may be, for example, a tissue, an artery, or a vein. In another aspect the device for perfusion management 100 has an auto- correct feature for correcting a sub-normal or abnormal gradient of temperature, pressure, flow concentration, or material concentration
Application Title: A Telescoping Perfusion Management System The telescoping perfusion management device 100 may be composed of materials known in the art, for example, a metal, a ceramic, a glass, a plastic, a polymer, a biologically compatible material, or a combination. For example, the telescoping perfusion management device 100 may be made of helically-coiled stainless steel wire and coated with a polymer, such as, Teflon™. In another example, the telescoping perfusion management device 100 maybe made of helically-coiled stainless steel wire and coated with a polymer and impregnated with one or more of a biological material, for example, including but not limited to, anti coagulants, or inhibitors.
B. Operation(s) and/or Process(es)
Some or even most of the components of the telescoping perfusion management device 100 may be present ex-vivo. In one implementation, the telescoping perfusion management device 100 is placed in proximity to the location on the animal, for example, the human body, and the extended part 104 directed to the selected location and an effective agent delivered in proximity to the selected location. The extended part 104 may be retracted after such a delivery, leaving the telescoping perfusion management device 100 in place at the location, until time for a future delivery of the effective agent or another operation. In this implementation, the majority of the telescoping perfusion management device 100 is ex vivo while the extended part 104 alternates between ex vivo and in vivo states.
In another aspect, some or all the components of the telescoping perfusion management device 100 are present in vivo. In one implementation, the telescoping perfusion management device 100 is placed in proximity to the location within the animal, for example, the human body, and the extended part 104 directed to a selected location and an effective agent delivered in proximity to the selected location. The extended part 104 may be retracted after such a delivery, leaving the telescoping perfusion management device 100 in place at the location, until time for a future delivery
Application Title: A Telescoping Perfusion Management System or another operation. In this implementation, the majority of the telescoping perfusion management devicelOO is in- vivo while the extended part 104 alternates between retracted, partially retracted or unretracted states.
In one implementation, the telescoping perfusion management device 100 is operable by a person. The person monitors, guides, positions, and performs other actions/operations or manages a response consistent with the telescoping perfusion management device 100 being managed by the person. In such an implementation a separate display device can present imagery to aid the person. The imagery may be captured as described above with reference to Figure 5, may be computer generated or may be captured by a separate imaging device internal to or external to the animal^ for example, the human body. Actions may be performed under control of the person who may be on site or may be linked from a remote location, or the telescoping perfusion management devicelOO may be programmed to perform some or all functions automatically. For example, the telescoping perfusion management device 100 maybe programmed to perform functions, such as, lumen clearance, lumen maintenance, monitoring of concentrations, sending of alerts, delivery of one or more of the effective agent at timed intervals or locations, self-check, and self-diagnosis. It will be appreciated by those of skill in the art that the telescoping perfusion management device 100 may be programmed for complete automatic operation of one or more functions.
C. Variation(s), and/or Implementation^)
Those having skill in the art will recognize that the present application teaches modifications of the devices, structures, and/or processes within the spirit of the teaching herein. For example, the telescoping perfusion management devicelOO need not be limited to managing perfus n. The device provides a mechanism for exploring one or more regions and/or reaching a location within an animal, obtaining information, cor-maunicating this information, performing operations, performing procedures, and providing treatment. In another example, the telescoping perfusion management de ice
Application Title: A Telescoping Perfusion Management System 100 may find utility in the management of physiological functions, the detection or elimination of pathological functions or conditions, and/or treatment of diseases of non- human animals. Other modifications of the subject matter herein will be appreciated by one of skill in the art in light of the teachings herein.
The foregoing described aspects depict different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively "associated" such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as "associated with" each other such that the desired functionaUty is achieved, irrespective of architectures or intermedia! components. Likewise, any two components so associated can also be viewed as being "operably connected", or "operably coupled", to each other to achieve the desired functionality.
While particular aspects of the present subject matter described herein have been shown and described, it will be obvious to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this subject matter described herein. Furthermore, it is to be understood that the invention is defined solely by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as "open" terms (e.g., the term "including" should be interpreted as "including but not limited to," the term "having" should be interpreted as "having at least," the term "includes" should be interpreted as "includes but is not limited to," etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the
Application Title: A Telescoping Perfusion Management System absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases "at least one" and "one or more" to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles "a" or "an" limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases "one or more" or "at least one" and indefinite articles such as "a" or "an" (e.g., "a" and/or "an" should typically be interpreted to mean "at least one" or "one or more"); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of "two recitations," without other modifiers, typically means at least two recitations, or two or more recitations), etc.
Application Title: A Telescoping Perfusion Management System

Claims

1. A system, comprising: a body portion; an extending part with a proximal end piece and a distal end piece and wherein the proximal end piece is coupled to the body portion; at least one receiving body in communication with the extending part; and a control circuit coupled to the receiving unit or the extending part.
2. The system of Claim 1 , wherein the extending part further comprises: a plurahty of shding pieces .
3. The system of Claim 2, wherein the plurahty of shding pieces -urther comprises: inwardly shding or outwardly shding pieces.
4. The system of Claim 2, wherein the plurality of shding pieces further comprises : a uniform, increasing, or decreasing size or dimension for traveling the interior of a blood vessel.
5. The system of Claim 2, wherein the plurahty of sliding pieces comprises: a hollow portion.
6. The system of Claim 2, wherein the plurahty of sliding pieces further comprises:
Application Title: A Telescoping Perfusion Management System a size or dimension wherein the diameter of a distal sliding piece is less than the size or dimension of an adjacent proximal sliding piece.
7. The system of Claim 2 or 6, wherein the plurahty of sliding pieces further comprises : a twofold decrease in a diameter of each of a successive distal sliding piece.
8. The system of Claim 2, wherein the plurality of sliding pieces further comprises: a distal end and a proximal end and wherein the distal end of each sliding piece is less than the size or dimension of the proximal end of each sliding piece.
9. The system of Claim 1, wherein the system further comprises: a pump, or a source of pressure coupled to the extending part.
10. The system of Claim 1, wherein the system further comprises: a motor or an actuator coupled to the extending part.
11. The system of Claim 1, wherein the system comprises: a polymer operative for converting a first form of energy to a second form of energy.
12. The system of Claim 11, wherein the system comprises: a polymer operative for converting electrical energy to mechanical energy.
13. The system of Claim 11, wherein the system comprises:
Application Title: A Telescoping Perfusion Management System a polymer operative for converting mechanical energy to electrical energy.
14. The system of Claim 1, wherein the extending part comprises: a polymer operative for converting one form of energy to a new form of energy.
15. The system of Claim 1, wherein the extending part comprises: a polymer that converts one form of energy to a new form of energy operative for moving fluid.
16. The system of Claim 1, wherein the extending part comprises a polymer that converts one form of energy to a new form of energy operative for providing a wave motion and moving a fluid.
17. The system of Claim 1, wherein the system further comprises: an imager, a pressure sensor, a temperature sensor, a chemical sensor, a gas sensor, an electrolyte sensor, a composition sensor, a concentration sensor, or a flow sensor coupled to the extending part.
18. The system of Claim 1, wherein the system --urther comprises: a wireless interface coupled to the control circuit
19. The system of Claim 1, wherein the system further comprises: a wireless data transmitter coupled to the control circuit or the extended part.
Application Title: A Telescoping Perfusion Management System
20. The system of Claim 1, wherein the system further comprises: a wireless data receiver, or a wireless data controller coupled to the extended part or the control circuit.
21. The system of Claim 1, wherein the at least one receiving body comprises: a source of a chemical, a chemical compound, a protein, a hpoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction internal or external to the at least one receiving body.
22. The system of Claim 1, wherein the at least one receiving body comprises: a source of two or more of a chemical, a chemical compound, a protein, a hpoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction internal or external to the at least one receiving body.
23. The system of Claim 1, wherein the system further comprises: a functional tool coupled to the extended part.
24. The system of Claim 23, wherein the functional tool further comprises: a tool positioner.
Application Title: A Telescoping Perfusion Management System
25. The system of Claim 23, wherein the functional tool further comprises: a tool for ablating, degrading or liquefying a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength.
26. The system of Claim 23, wherein the functional tool further comprises: a second control circuit for guiding the functional tool coupled to the control circuit.
27. The system of Claim 1, wherein the extended part further comprises: a source of an electric charge or electromagnetic radiation coupled or carried by the extended part.
28. The system of Claim 1, wherein the extended part further comprises: a device for fully, partially blocking, guiding, or shunting a liquid flow.
29. The system of Claim 1, wherein the system further comprises: a tool for cauterizing or sealing a cell, amass of cells, a tissue, or an assembly of biological materials exhibiting shear strength coupled to or carried by the extended part.
30. The system of Claim 1, wherein the system further comprises: a fluid dispenser coupled to or carried by the extended part.
31. The system of Claim 1, wherein the system further comprises:
Application Title: A Telescoping Perfusion Management System a stent coupled to or carried by the extended part.
32. The system of Claim 1, wherein the control circuit comprises: a configuration operative for controlling, guiding or positioning the extended part.
33. The system of Claim 1, wherein the control circuit comprises: a processor, a feedback circuit, or a logic circuit.
34. The system of Claim 1, wherein the control circuit further comprises: a processor further comprising a stored software or firmware program cooperative with the processor.
35. The system of Claim 1, wherein the system further comprises: a size, composition, shape, power dissipation level, or a configuration for implantation in an animal.
36. The system of Claim 35, wherein the --nimal comprises: a human.
37. The system of Claim 1, wherein the system further comprises: a configuration for placing in a location and operative for monitoring or treating one or more physiological variables.
38. The system of Claim 37, wherein the location comprises:
Application Title: A Telescoping Perfusion Management System a circulatory system, an abdominal aorta, a vena cava, or a nervous system.
39. The system of Claim 1, wherein the system comprises: a configuration for monitoring or treating a response in an animal.
40. The system of Claim 1, wherein the system further comprises: a medicinal agent, a pharmaceutical agent, a therapeutic device or assembly carried by the extending part to a location in an animal.
41. The system of Claim 1, wherein the system comprises: a configuration for communicating exterior to a patient.
Application Title: A Telescoping Perfusion Management System
42. A method of making a device for perfusion management, comprising: forming a hollow part for storing a receivable; coupling a flexible finger to the hollow part and configuring the flexible finger for extending from the hollow part to a location in an animal; and coupling the flexible finger to the hollow portion and to a control system including logic or software operable for dehvering the receivable from the hollow part to the location in the animal.
43. The method of Claim 42, wherein the flexible finger further comprises: a plurality of hollow shding parts.
44. The method of Claim 43, wherein the flexible finger further comprises: inwardly or outwardly shding parts.
45. The method of Claim 43 wherein the method further comprises: forming the flexible finger including the plurality of hollow sliding parts with a uniform, increasing, or decreasing size or dimensions for traveling the interior of a blood vessel.
46. The method of Claim 43, wherein the method further comprises: forming the flexible finger including the plurality of hollow sliding parts with a size or dimension wherein the diameter of a distal hollow sliding part is less than the size or dimension of an adjacent proximal hollow sliding part.
Application Title: A Telescoping Perfusion Management System
47. The method of Claim 43, wherein the method further comprises: forming a two-fold decrease in a diameter of each of a successive hollow sliding part.
48. The method of Claim 43, wherein the method further comprises: forming the flexible finger including the plurality of hollow sliding parts wherein the plurality of hollow sliding parts comprises a distal end and a proximal end and wherein the distal end of each sliding part is less than the size or dimension of the proximal end of each shding part.
49. The method of Claim 42, wherein the method further comprises: coupling a pump, or a source of pressure to the flexible finger.
50. The method of Claim 42, wherein the method further comprises: coupling a motor or an actuator to the flexible finger.
51. The method of Claim 42, wherein the method further comprises: including a polymer coupled to the flexible finger operative for converting a first form of energy to a second form of energy.
52. The method of Claim 42, wherein the method further comprises: including a polymer coupled to the flexible finger operative for converting electrical energy to mechanical energy.
Application Title: A Telescoping Perfusion Management System
53. The method of Claim 42, wherein the method further comprises: providing a polymer coupled to the flexible finger operative for converting one form of energy to a new form of energy and moving a fluid through the flexible finger.
54. The method of Claim 42, wherein the method further comprises: including a polymer coupled to the flexible finger operative for converting one form of energy to a new form of energy operative for providing a peristaltic wave and moving a fluid.
55. The method of Claim 42, wherein the method further comprises: providing a sensor coupled to or carried by the flexible finger.
56. The method of Claim 42, wherein the method comprises: coupling an imager, a pressure sensor, a temperature sensor, a chemical sensor, a gas sensor, an electrolyte sensor, a composition sensor, a concentration sensor, or a flow sensor to the flexible finger.
57. The method of Claim 42, wherein the method comprises: providing a wireless interface coupled to the control system.
58. The method of Claim 42, wherein the method comprises: coupling a wireless data transmitter coupled to the control system or the flexible finger.
Application Title: A Telescoping Perfusion Management System
59. The method of Claim 42, wherein the method comprises: coupling a wireless data receiver, or a wireless data controller to the flexible finger or the control system.
60. The method of Claim 42, wherein the method comprises: coupling a source of a chemical, a chemical compound, a protein, a hpoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction internal or external to the hollow part.
61. The method of Claim 42, wherein the method comprises: coupling a source of two or more of a chemical, a chemical compound, a protein, a hpoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction internal or external to the hollow part.
62. The method of Claim 1, wherein the method fr-rther comprises: including a functional tool coupled to or carried by the flexible finger.
63. The method of Claim 62, wherein the functional tool further comprises: including a tool positioner carried by the flexible finger.
Application Title: A Telescoping Perfusion Management System
64. The method of Claim 62, wherein the functional tool further comprises: including a tool for ablating, degrading or liquefying a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength coupled to the flexible finger.
65. The method of Claim 62, wherein the functional tool further comprises providing a tool for cauterizing or sealing a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength coupled to or carried by the flexible finger.
66. The method of Claim 62, wherein the method comprises: providing a control circuit for guiding the functional tool coupled to the control circuit.
67. The method of Claim 42, wherein the method further comprises: providing a source of an electric charge or electromagnetic radiation coupled or carried by the flexible finger.
68. The method of Claim 42, wherein the method further comprises: providing a device for fully, partially blocking, guiding, or shunting a hquid flow coupled to the flexible finger.
69. The method of Claim 42, wherein the method further comprises: providing a fluid dispenser coupled to or carried by the flexible finger.
Application Title: A Telescoping Perfusion Management System
70. The method of Claim 42, wherein the method further comprises: providing a stent coupled to or carried by the flexible finger.
71. The method of Claim 42, wherein the method comprises: fomώig a configuration operative for controlling, guiding or positioning the flexible part and coupled to the control system.
72. The method of Claim 42, wherein the method further comprises:
providing a processor, a logic circuit, or a feedback circuit coupled to the control system.
73. The method of Claim 42, wherein the method further comprises: providing a processor further comprising a stored software or firmware program cooperative with the processor.
74. The method of Claim 42, wherein the method further comprises: fo-rming the device for perfusion management with a size, composition, shape, power dissipation level, or configuration for implantation in an animal.
75. The method of Claim 42, wherein the method further comprises: forming the device for perfusion management having a size, composition, shape, power dissipation level, or configuration for implantation in animal wherein the --nimal is a human.
76. The method of Claim 42, wherein the method further comprises:
Application Title: A Telescoping Perfusion Management System forming the device for perfusion management having a configuration for placing in a location and operative for monitoring or treating one or more physiological variables.
77. The method of Claim 76, wherein the method further comprises: forming the device for perfusion management having a configuration for placing in the location and operative for monitoring or treating one or more physiological variables and wherein the location is a circulatory system, an abdominal aorta, a vena cava, or a nervous system.
78. The method of Claim 42, wherein the method further comprises: forming the device for perfusion management having a configuration for monitoring or treating a response in an animal.
79. The method of Claim 42, wherein the method further comprises: forming the device for perfusion management having a configuration for dehvering a medicinal agent, a pharmaceutical agent, a therapeutic device or assembly to a location in an animal.
80. The system of Claim 42, wherein the method comprises: configuring the device for perfusion management for communicating exterior to a patient.
Application Title: A Telescoping Perfusion Management System
81. A method for perfusion management, comprising: storing a receivable in a cavity; extending a tractable conduit between the cavity and a location in an animal; and delivering the receivable to the location in the animal.
82. The method of Claim 81, wherein the method further comprises: guiding, positioning, or directing the tractable conduit for traveling the interior of a blood vessel.
83. The method of Claim 81, wherein the method further comprises: charging a polymer to make a wave motion and move contents of the tractable conduit or the cavity.
84. The method of Claim 81, wherein the method further comprises: charging a polymer to perform an action.
85. The method of Claim 81, wherein the method comprises: imaging, or detecting a level of pressure, temperature, chemical, gas, electrolyte, composition, concentration, or flow.
86. The method of Claim 81 , wherein the method further comprises: delivering chemicals, chemical compounds, proteins, lipoproteins, glycoproteins, sugars, lipids, antigens, antibodies, cytokines, peptides, neurotransmitters,
Application Title: A Telescoping Perfusion Management System hormones, ions, messenger molecules, nucleic acids, engineered nucleic acids, nucleic acid vectors, drugs, cells, cell fragments, cell organelles, liposomes, pharmaceutical agents, biological materials, or biological fractions in proximity to the location in the --nimal.
87. The method of Claim 81, wherein the method further comprises: performing one or more operations or actions.
88. The method of Claim 81 , wherein the method further comprises: positioning tools in the animal.
89. The method of Claim 81 , wherein the method further comprises: fully or partially blocking or shunting a Hquid flow.
90. The method of Claim 81 , wherein the method further comprises: ablating, degrading, or liquefying a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength.
91. The method of Claim 81, wherein the method ft-rther comprises: captiiring a cell, a tissue, a fluid, a gel, a sample, a colloid, and emulsion, a debris, a contaminant, or a biological material.
92. The method of Claim 81, wherein the method further comprises: sampling a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength.
Application Title: A Telescoping Perfusion Management System
93. The method of Claim 81, wherein the method further comprises: cauterizing or sealing a cell, a mass of cells, a tissue, or an assembly of biological materials exhibiting shear strength.
94. The method of Claim 81, wherein the method further comprises: dispensing a fluid at a controlled rate.
95. The method according to Claim 81, wherein the method further comprises: controlling or guiding the tractable conduit.
96. The method according to Claim 81, wherein the method further comprises: configuring the device for perfusion management for placing in the animal wherein the animal is a human
97. The method according to Claim 96, wherein the method further comprises: configuring the device for perfusion management for placing in a new location in the human.
98. The method according to Claim 81, wherein the method further comprises: configuring the device for perfusion management for placing in a circulatory system, an aorta, in a vena cava or in a nervous system.
99. The method according to Claim 81, wherein the method further comprises:
Application Title: A Telescoping Perfusion Management System releasing an electric current or an electromagnetic radiation in proximity to a cell, a tissue, or an assembly of biological materials exhibiting shear strength.
Application Title: A Telescoping Perfusion Management System
PCT/US2005/013346 2004-04-19 2005-04-19 A telescoping perfusion management system WO2005102408A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10/827,576 US8337482B2 (en) 2004-04-19 2004-04-19 System for perfusion management
US10/827,572 2004-04-19
US10/827,390 2004-04-19
US10/827,578 2004-04-19
US10/827,576 2004-04-19
US10/827,578 US20050234440A1 (en) 2004-04-19 2004-04-19 System with a sensor for perfusion management
US10/827,390 US8361013B2 (en) 2004-04-19 2004-04-19 Telescoping perfusion management system
US10/827,572 US7850676B2 (en) 2004-04-19 2004-04-19 System with a reservoir for perfusion management

Publications (2)

Publication Number Publication Date
WO2005102408A2 true WO2005102408A2 (en) 2005-11-03
WO2005102408A3 WO2005102408A3 (en) 2007-05-10

Family

ID=35097215

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/013346 WO2005102408A2 (en) 2004-04-19 2005-04-19 A telescoping perfusion management system

Country Status (2)

Country Link
US (5) US7850676B2 (en)
WO (1) WO2005102408A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US20080058786A1 (en) * 2006-04-12 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US8936629B2 (en) * 2006-04-12 2015-01-20 Invention Science Fund I Llc Autofluorescent imaging and target ablation
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9737657B2 (en) 2010-06-03 2017-08-22 Medtronic, Inc. Implantable medical pump with pressure sensor
US8397578B2 (en) 2010-06-03 2013-03-19 Medtronic, Inc. Capacitive pressure sensor assembly
JP2014500538A (en) 2010-10-12 2014-01-09 タニス,ケヴィン ジェイ. Medical equipment
US9737649B2 (en) 2013-03-14 2017-08-22 Smith & Nephew, Inc. Systems and methods for applying reduced pressure therapy
KR102624370B1 (en) 2014-03-21 2024-01-15 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
US11315681B2 (en) 2015-10-07 2022-04-26 Smith & Nephew, Inc. Reduced pressure therapy device operation and authorization monitoring
US11406736B2 (en) 2016-01-13 2022-08-09 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Vascular extracellular matrix hydrogel
AU2017261814B2 (en) 2016-05-13 2022-05-19 Smith & Nephew, Inc. Automatic wound coupling detection in negative pressure wound therapy systems
TWI606808B (en) * 2016-07-15 2017-12-01 曾錦順 Egg-shaped colonoscopy and the marching control method thereof
CN106580385A (en) * 2016-12-13 2017-04-26 庞继恩 Visual amplatzer conveying and positioning apparatus for interventional therapy of congenital heart disease
US11712508B2 (en) 2017-07-10 2023-08-01 Smith & Nephew, Inc. Systems and methods for directly interacting with communications module of wound therapy apparatus
JP2022540932A (en) * 2019-07-15 2022-09-20 ソウル ナショナル ユニバーシティ ホスピタル An intraperitoneal gas delivery system including an intraperitoneal hot pressurized gas circulation system and a two-fluid nozzle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295990B1 (en) * 1998-02-03 2001-10-02 Salient Interventional Systems, Inc. Methods and systems for treating ischemia

Family Cites Families (340)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US272806A (en) * 1883-02-20 Dyson d
US214579A (en) * 1879-04-22 Improvement in vehicle running-gears
US74479A (en) * 1868-02-18 Horace b
US158584A (en) * 1875-01-12 Improvement in brick-wlachines
US65592A (en) * 1867-06-11 Island
US163177A (en) * 1875-05-11 Improvement in boiler feeders and regulators
US3391697A (en) 1965-09-20 1968-07-09 Medtronic Inc Runaway inhibited pacemaker
US3837339A (en) 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US4267831A (en) 1979-09-24 1981-05-19 Aguilar Rogelio M Nasal air filter and medicament dispenser device
US4367741A (en) * 1980-12-22 1983-01-11 Alza Corporation Dispenser powered by cross-linked hydrophilic polymer grafted to hydrophilic polymer
US4583190A (en) 1982-04-21 1986-04-15 Neuroscience, Inc. Microcomputer based system for performing fast Fourier transforms
US4771772A (en) 1982-08-09 1988-09-20 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4628928A (en) 1982-08-09 1986-12-16 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4714460A (en) 1983-07-29 1987-12-22 Reynaldo Calderon Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency
US4800898A (en) 1983-10-07 1989-01-31 Cordis Corporation Neural stimulator electrode element and lead
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
US4585652A (en) 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4817601A (en) 1985-03-06 1989-04-04 C. R. Bard, Inc. Catheter system for controlled removal by radiant energy of biological obstructions
US4769006A (en) 1985-05-13 1988-09-06 Kos Medical Technologies, Ltd. Hydrodynamically propelled pacing catheter
GR851148B (en) 1985-05-13 1985-05-22 Papantonakos Apostolos
US4750488A (en) 1986-05-19 1988-06-14 Sonomed Technology, Inc. Vibration apparatus preferably for endoscopic ultrasonic aspirator
US5019372A (en) 1986-06-27 1991-05-28 The Children's Medical Center Corporation Magnetically modulated polymeric drug release system
US4763667A (en) 1986-09-19 1988-08-16 Microvasive, Inc. Tissue-penetrating catheter device
GB8701731D0 (en) * 1987-01-27 1987-03-04 Patcentre Benelux Nv Sa Pumps
US4854315A (en) 1987-06-25 1989-08-08 Stack Richard S Laser catheter
US4795434A (en) 1987-09-10 1989-01-03 C. R. Bard, Inc. Apparatus for positioning a sensor in vivo
US5153827A (en) 1989-01-30 1992-10-06 Omni-Flow, Inc. An infusion management and pumping system having an alarm handling system
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5176638A (en) 1990-01-12 1993-01-05 Don Michael T Anthony Regional perfusion catheter with improved drug delivery control
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
JPH07115233B2 (en) * 1990-08-10 1995-12-13 株式会社ヨシツカ精機 Powder molding press
US5188111A (en) 1991-01-18 1993-02-23 Catheter Research, Inc. Device for seeking an area of interest within a body
US5269303A (en) 1991-02-22 1993-12-14 Cyberonics, Inc. Treatment of dementia by nerve stimulation
US5335657A (en) 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5279607A (en) 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process
US5688269A (en) 1991-07-10 1997-11-18 Electroscope, Inc. Electrosurgical apparatus for laparoscopic and like procedures
US5234457A (en) 1991-10-09 1993-08-10 Boston Scientific Corporation Impregnated stent
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
WO1993009018A1 (en) 1991-11-05 1993-05-13 Seiko Epson Corporation Micro-robot
US5339051A (en) 1991-12-09 1994-08-16 Sandia Corporation Micro-machined resonator oscillator
US5437660A (en) 1991-12-30 1995-08-01 Trimedyne, Inc. Tissue ablation and a lateral-lasing fiber optic device therefor
US6296638B1 (en) * 1993-05-10 2001-10-02 Arthrocare Corporation Systems for tissue ablation and aspiration
US6963792B1 (en) 1992-01-21 2005-11-08 Sri International Surgical method
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
WO1995014500A1 (en) 1992-05-01 1995-06-01 Beth Israel Hospital A stent
US5310404A (en) 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
JP2855304B2 (en) 1992-06-02 1999-02-10 富士写真フイルム株式会社 Silver halide color photographic materials
US5338625A (en) 1992-07-29 1994-08-16 Martin Marietta Energy Systems, Inc. Thin film battery and method for making same
EP0580928A1 (en) 1992-07-31 1994-02-02 ARIES S.r.l. A spinal electrode catheter
US5306294A (en) 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5662587A (en) 1992-09-16 1997-09-02 Cedars Sinai Medical Center Robotic endoscopy
US5337732A (en) 1992-09-16 1994-08-16 Cedars-Sinai Medical Center Robotic endoscopy
DE4239987C2 (en) 1992-11-27 1996-07-11 Siemens Ag Self-moving unit for movement between opposing wall surfaces
US5353807A (en) 1992-12-07 1994-10-11 Demarco Thomas J Magnetically guidable intubation device
US5339851A (en) * 1992-12-30 1994-08-23 Miller Mark W Assembly for attaching a removable tent to a motor vehicle
US5314451A (en) 1993-01-15 1994-05-24 Medtronic, Inc. Replaceable battery for implantable medical device
US5403311A (en) 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5873835A (en) 1993-04-29 1999-02-23 Scimed Life Systems, Inc. Intravascular pressure and flow sensor
US5670329A (en) 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
US5728089A (en) 1993-06-04 1998-03-17 The Regents Of The University Of California Microfabricated structure to be used in surgery
WO1994030030A1 (en) 1993-06-04 1994-12-22 The Regents Of The University Of California Microfabricated acoustic source and receiver
US5386741A (en) 1993-06-07 1995-02-07 Rennex; Brian G. Robotic snake
DE4319812C1 (en) 1993-06-15 1995-02-09 Zurbruegg Heinz R Implantable ultrasound probe for measuring the flow rate of blood in humans and animals
US5497147A (en) 1993-06-21 1996-03-05 Microstrain, Company Differential variable reluctance transducer
DE69432148T2 (en) 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5921982A (en) 1993-07-30 1999-07-13 Lesh; Michael D. Systems and methods for ablating body tissue
US5807395A (en) 1993-08-27 1998-09-15 Medtronic, Inc. Method and apparatus for RF ablation and hyperthermia
US5398670A (en) 1993-08-31 1995-03-21 Ethicon, Inc. Lumen traversing device
US5476450A (en) 1993-11-04 1995-12-19 Ruggio; Joseph M. Apparatus and method for aspirating intravascular, pulmonary and cardiac obstructions
WO1995019567A1 (en) 1994-01-13 1995-07-20 The Trustees Of Columbia University In The City Of New York Synthetic receptors, libraries and uses thereof
US6797522B1 (en) 1994-01-13 2004-09-28 The Trustees Of Columbia University In The City Of New York Synthetic receptors
SE9400088D0 (en) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
IL108352A (en) * 1994-01-17 2000-02-29 Given Imaging Ltd In vivo video camera system
US6102845A (en) 1994-02-07 2000-08-15 Baxter International Inc. Ventricular assist device with minimal blood contacting surfaces
CA2145232A1 (en) 1994-03-24 1995-09-25 Arie Avny Viewing method and apparatus particularly useful for viewing the interior of the large intestine
US5591139A (en) 1994-06-06 1997-01-07 The Regents Of The University Of California IC-processed microneedles
DE69529338T3 (en) 1994-07-08 2007-05-31 Ev3 Inc., Plymouth Intravascular filter device
US5695457A (en) 1994-07-28 1997-12-09 Heartport, Inc. Cardioplegia catheter system
US5908027A (en) 1994-08-22 1999-06-01 Alaris Medical Systems, Inc. Tonometry system for monitoring blood pressure
DE69533227T2 (en) 1994-10-28 2005-07-07 Advanced Medical Solutions Ltd., Winsford REHYDRATED HYDROGEL
US5551953A (en) 1994-10-31 1996-09-03 Alza Corporation Electrotransport system with remote telemetry link
US5643296A (en) 1994-12-16 1997-07-01 Devices For Vasclar Intervention Intravascular catheter with guiding structure
US5632754A (en) 1994-12-23 1997-05-27 Devices For Vascular Intervention Universal catheter with interchangeable work element
US5964773A (en) 1995-02-15 1999-10-12 Automated Medical Products, Inc. Laparascopic suturing device and suture needles
US5643246A (en) 1995-02-24 1997-07-01 Gel Sciences, Inc. Electromagnetically triggered, responsive gel based drug delivery device
US5599324A (en) 1995-05-04 1997-02-04 Boston Scientific Corporation Catheter for administering a liquid agent
US6575969B1 (en) 1995-05-04 2003-06-10 Sherwood Services Ag Cool-tip radiofrequency thermosurgery electrode system for tumor ablation
US6255361B1 (en) 1995-11-21 2001-07-03 Acushnet Company Golf ball compositions and method of making same
PT876165E (en) 1995-12-18 2006-10-31 Angiotech Biomaterials Corp COMPOSITIONS OF RETICULATED POLYMERS AND PROCESSES FOR THEIR USE
US5683432A (en) 1996-01-11 1997-11-04 Medtronic, Inc. Adaptive, performance-optimizing communication system for communicating with an implanted medical device
US6475639B2 (en) 1996-01-18 2002-11-05 Mohsen Shahinpoor Ionic polymer sensors and actuators
WO1997027893A1 (en) 1996-02-02 1997-08-07 Transvascular, Inc. Methods and apparatus for blocking flow through blood vessels
US5624398A (en) 1996-02-08 1997-04-29 Symbiosis Corporation Endoscopic robotic surgical tools and methods
US6152899A (en) 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
UA48221C2 (en) 1996-04-01 2002-08-15 Валєрій Івановіч Кобозєв Electrical gastro-intestinal tract stimulator
US5830179A (en) 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US5800421A (en) 1996-06-12 1998-09-01 Lemelson; Jerome H. Medical devices using electrosensitive gels
US5782798A (en) 1996-06-26 1998-07-21 Medtronic, Inc. Techniques for treating eating disorders by brain stimulation and drug infusion
US5737279A (en) 1996-08-07 1998-04-07 The United States Of America As Represented By The Secretary Of The Navy Retractable sensor array system
US5702432A (en) 1996-10-03 1997-12-30 Light Sciences Limited Partnership Intracorporeal light treatment of blood
US6058323A (en) 1996-11-05 2000-05-02 Lemelson; Jerome System and method for treating select tissue in a living being
US6197013B1 (en) 1996-11-06 2001-03-06 Setagon, Inc. Method and apparatus for drug and gene delivery
US5854078A (en) 1996-11-06 1998-12-29 University Of Pittsburgh Polymerized crystalline colloidal array sensor methods
US6019729A (en) 1996-11-15 2000-02-01 Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho Sensor mechanism-equipped catheter
US6410046B1 (en) 1996-11-19 2002-06-25 Intrabrain International Nv Administering pharmaceuticals to the mammalian central nervous system
ES2208963T3 (en) 1997-01-03 2004-06-16 Biosense, Inc. PRESSURE SENSITIVE VASCULAR ENDOPROTESIS.
US5705293A (en) 1997-01-09 1998-01-06 Lockheed Martin Energy Research Corporation Solid state thin film battery having a high temperature lithium alloy anode
US6695885B2 (en) 1997-02-26 2004-02-24 Alfred E. Mann Foundation For Scientific Research Method and apparatus for coupling an implantable stimulator/sensor to a prosthetic device
US6164284A (en) 1997-02-26 2000-12-26 Schulman; Joseph H. System of implantable devices for monitoring and/or affecting body parameters
AU6667698A (en) 1997-02-26 1998-09-18 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
US6111520A (en) 1997-04-18 2000-08-29 Georgia Tech Research Corp. System and method for the wireless sensing of physical properties
KR100454157B1 (en) 1997-05-07 2004-10-26 컴퓨메딕스 슬립 피티와이. 리미티드 Apparatus for controlling gas delivery to patient
BR9815499A (en) 1997-07-02 2001-01-02 Euro Celtique Sa Prolonged anesthesia in joints and body spaces.
US5954675A (en) 1997-07-07 1999-09-21 Dellagatta; Enrico Michael Method of ultrasonic therapy
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6086528A (en) * 1997-09-11 2000-07-11 Adair; Edwin L. Surgical devices with removable imaging capability and methods of employing same
US6409674B1 (en) 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6585763B1 (en) 1997-10-14 2003-07-01 Vascusense, Inc. Implantable therapeutic device and method
US5908435A (en) 1997-10-23 1999-06-01 Samuels; Shaun L. W. Expandable lumen device and method of use
US6240312B1 (en) 1997-10-23 2001-05-29 Robert R. Alfano Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment
US6597954B1 (en) 1997-10-27 2003-07-22 Neuropace, Inc. System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes
US6016449A (en) 1997-10-27 2000-01-18 Neuropace, Inc. System for treatment of neurological disorders
US5947119A (en) 1997-10-31 1999-09-07 Reznick; Jerald M. Therapeutic process and apparatus for nasal passages
US5931788A (en) * 1997-12-05 1999-08-03 Keen; Richard R. Method and apparatus for imaging internal organs and vascular structures through the gastrointestinal wall
WO1999029298A2 (en) 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
US6186986B1 (en) 1998-01-21 2001-02-13 St. Jude Medical Cardiovascular Group, Inc. Micro-catheters and methods of their manufacture
US6261312B1 (en) 1998-06-23 2001-07-17 Innercool Therapies, Inc. Inflatable catheter for selective organ heating and cooling and method of using the same
US6843800B1 (en) 1998-01-23 2005-01-18 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6045551A (en) 1998-02-06 2000-04-04 Bonutti; Peter M. Bone suture
US6755803B1 (en) 1998-02-06 2004-06-29 Possis Medical, Inc. Single operator exchange fluid jet thrombectomy device
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
US6278379B1 (en) 1998-04-02 2001-08-21 Georgia Tech Research Corporation System, method, and sensors for sensing physical properties
US6219577B1 (en) 1998-04-14 2001-04-17 Global Vascular Concepts, Inc. Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues
US6249076B1 (en) 1998-04-14 2001-06-19 Massachusetts Institute Of Technology Conducting polymer actuator
US7647237B2 (en) 1998-04-29 2010-01-12 Minimed, Inc. Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like
US6018682A (en) 1998-04-30 2000-01-25 Medtronic, Inc. Implantable seizure warning system
US6206914B1 (en) 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6294281B1 (en) 1998-06-17 2001-09-25 Therasense, Inc. Biological fuel cell and method
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6735474B1 (en) 1998-07-06 2004-05-11 Advanced Bionics Corporation Implantable stimulator system and method for treatment of incontinence and pain
US6497714B1 (en) 1998-07-16 2002-12-24 Olympus Optical Co., Ltd. Ultrasonic trocar
US6240316B1 (en) * 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US7235096B1 (en) 1998-08-25 2007-06-26 Tricardia, Llc Implantable device for promoting repair of a body lumen
ES2306525T3 (en) 1998-08-26 2008-11-01 Sensors For Medicine And Science, Inc. OPTICAL-BASED DETECTION DEVICES.
US6385472B1 (en) 1999-09-10 2002-05-07 Stereotaxis, Inc. Magnetically navigable telescoping catheter and method of navigating telescoping catheter
US6358276B1 (en) 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6530950B1 (en) 1999-01-12 2003-03-11 Quanam Medical Corporation Intraluminal stent having coaxial polymer member
JP2002537031A (en) 1999-02-18 2002-11-05 バイオバルブ テクノロジーズ インコーポレイテッド Electroactive pores
US8636648B2 (en) 1999-03-01 2014-01-28 West View Research, Llc Endoscopic smart probe
US6464687B1 (en) 1999-03-09 2002-10-15 Ball Semiconductor, Inc. Implantable drug delivery system
US6170488B1 (en) 1999-03-24 2001-01-09 The B. F. Goodrich Company Acoustic-based remotely interrogated diagnostic implant device and system
US6436120B1 (en) 1999-04-20 2002-08-20 Allen J. Meglin Vena cava filter
US20050113460A1 (en) 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US6179789B1 (en) 1999-05-03 2001-01-30 Lily Chen Tu Enhanced radioactive stent for reduction of restenosis
US6149603A (en) 1999-05-14 2000-11-21 Ventrex, Inc. Method and apparatus for determining whether an intubated patient has been properly intubated
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6464625B2 (en) 1999-06-23 2002-10-15 Robert A. Ganz Therapeutic method and apparatus for debilitating or killing microorganisms within the body
US7247138B2 (en) * 1999-07-01 2007-07-24 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US6512949B1 (en) 1999-07-12 2003-01-28 Medtronic, Inc. Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto
US7064472B2 (en) 1999-07-20 2006-06-20 Sri International Electroactive polymer devices for moving fluid
GB2352636B (en) 1999-08-03 2003-05-14 Univ College London Hospitals Improved passage-travelling device
WO2001012157A1 (en) 1999-08-18 2001-02-22 Microchips, Inc. Thermally-activated microchip chemical delivery devices
US6666860B1 (en) 1999-08-24 2003-12-23 Olympus Optical Co., Ltd. Electric treatment system
US6802811B1 (en) 1999-09-17 2004-10-12 Endoluminal Therapeutics, Inc. Sensing, interrogating, storing, telemetering and responding medical implants
US6440082B1 (en) 1999-09-30 2002-08-27 Medtronic Physio-Control Manufacturing Corp. Method and apparatus for using heart sounds to determine the presence of a pulse
CN1195458C (en) 1999-10-04 2005-04-06 清水庆彦 Artificial trachea
US6882881B1 (en) 1999-10-19 2005-04-19 The Johns Hopkins University Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders
US6383162B1 (en) 1999-11-12 2002-05-07 Paul H. Sugarbaker Apparatus and method for abdomino-pelvic chemotherapy perfusion and lavage
US6491666B1 (en) 1999-11-17 2002-12-10 Microchips, Inc. Microfabricated devices for the delivery of molecules into a carrier fluid
US7195641B2 (en) * 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6548982B1 (en) 1999-11-19 2003-04-15 Regents Of The University Of Minnesota Miniature robotic vehicles and methods of controlling same
US6673042B1 (en) 1999-11-22 2004-01-06 Wilfred J. Samson Expandable venous cannula and method of use
US6861001B2 (en) 1999-12-02 2005-03-01 The General Hospital Corporation Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
US6592567B1 (en) 1999-12-07 2003-07-15 Chf Solutions, Inc. Kidney perfusion catheter
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6450937B1 (en) 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
GB9930000D0 (en) 1999-12-21 2000-02-09 Phaeton Research Ltd An ingestible device
US7483743B2 (en) 2000-01-11 2009-01-27 Cedars-Sinai Medical Center System for detecting, diagnosing, and treating cardiovascular disease
US6974437B2 (en) * 2000-01-21 2005-12-13 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US7039453B2 (en) 2000-02-08 2006-05-02 Tarun Mullick Miniature ingestible capsule
US6920359B2 (en) 2000-02-15 2005-07-19 Advanced Bionics Corporation Deep brain stimulation system for the treatment of Parkinson's Disease or other disorders
CA2400325A1 (en) 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for delivering agents using alternating current
US7131979B2 (en) 2002-05-17 2006-11-07 Dvl Acquisition Sub, Inc. Surgical suturing instrument and method of use
AU5113401A (en) 2000-03-31 2001-10-15 Rita Medical Systems Inc Tissue biopsy and treatment apparatus and method
US6398280B1 (en) 2000-05-11 2002-06-04 Zyvex Corporation Gripper and complementary handle for use with microcomponents
US7181261B2 (en) 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
US6442413B1 (en) 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US6402678B1 (en) 2000-07-31 2002-06-11 Neuralieve, Inc. Means and method for the treatment of migraine headaches
US6921413B2 (en) 2000-08-16 2005-07-26 Vanderbilt University Methods and devices for optical stimulation of neural tissues
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6898464B2 (en) 2000-10-05 2005-05-24 Innersea Technology Optical telemetry of data and power for wireless biomedical sensors and actuators
AU2002224453A1 (en) 2000-10-11 2002-04-22 Microchips, Inc. Microchip reservoir devices and facilitated corrosion of electrodes
US6974445B2 (en) * 2000-11-03 2005-12-13 Endoart Sa Implantable medical device for delivering a liquid
US6514237B1 (en) 2000-11-06 2003-02-04 Cordis Corporation Controllable intralumen medical device
US6929636B1 (en) 2000-11-08 2005-08-16 Hewlett-Packard Development Company, L.P. Internal drug dispenser capsule medical device
US6591137B1 (en) 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US6679893B1 (en) 2000-11-16 2004-01-20 Chestnut Medical Technologies, Inc. Grasping device and method of use
US8372139B2 (en) 2001-02-14 2013-02-12 Advanced Bio Prosthetic Surfaces, Ltd. In vivo sensor and method of making same
US6607553B1 (en) 2000-11-17 2003-08-19 B. Braun Medical, Inc. Method for deploying a thermo-mechanically expandable stent
US6950707B2 (en) 2000-11-21 2005-09-27 Advanced Bionics Corporation Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion
WO2002055136A2 (en) 2000-12-01 2002-07-18 Nephros Therapeutics Inc Intrasvascular drug delivery device and use therefor
AU2002248196A1 (en) 2000-12-15 2002-08-12 Tony R. Brown Atrial fibrillation rf treatment device and method
US6384741B1 (en) * 2001-01-16 2002-05-07 O'leary, Sr. Jerry P. Apparatus and method for providing high mounted view of traffic
US6735475B1 (en) 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
US6754536B2 (en) 2001-01-31 2004-06-22 Medtronic, Inc Implantable medical device affixed internally within the gastrointestinal tract
US6571125B2 (en) * 2001-02-12 2003-05-27 Medtronic, Inc. Drug delivery device
US20020116034A1 (en) 2001-02-20 2002-08-22 Victor Miller Controllable, wearable MRI-compatible pacemaker with power carrying photonic catheter and VOO functionality
US20020116028A1 (en) 2001-02-20 2002-08-22 Wilson Greatbatch MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality
ITBO20010110A1 (en) * 2001-03-01 2002-09-01 Tre Esse Progettazione Biomedi PROCEDURE AND IMPLANTABLE DEVICE FOR THE INTRA-PULMONARY MEASUREMENT OF PHYSICAL PROPERTIES OF THE PULMONARY FABRIC DEPENDENT ON ITS DENSIT
US6592549B2 (en) 2001-03-14 2003-07-15 Scimed Life Systems, Inc. Rapid exchange stent delivery system and associated components
US20020188323A1 (en) 2001-03-19 2002-12-12 Remon Medical Technologies Ltd. Methods, systems and devices for in vivo electrochemical production of therapeutic agents
US20020147480A1 (en) 2001-04-04 2002-10-10 Mamayek Donald S. Treatment of lipid pool
EP1418845A4 (en) 2001-04-04 2006-06-07 Given Imaging Ltd Induction powered in vivo imaging device
US6616676B2 (en) 2001-04-10 2003-09-09 Scimed Life Systems, Inc. Devices and methods for removing occlusions in vessels
US7083593B2 (en) * 2001-04-18 2006-08-01 Advanced Bionics Corporation Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter
US6837901B2 (en) 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US20040225326A1 (en) 2001-05-07 2004-11-11 Weiner Mike L. Apparatus for the detection of restenosis
US20020169436A1 (en) 2001-05-08 2002-11-14 Hitinder Gurm Percutaneous method of preventing distal embolisation while maintaining adequate distal perfusion in percutaneous interventional procedures
KR100426613B1 (en) 2001-05-19 2004-04-08 한국과학기술연구원 Micro robot driving system
KR100402920B1 (en) 2001-05-19 2003-10-22 한국과학기술연구원 Micro robot
US6733485B1 (en) 2001-05-25 2004-05-11 Advanced Bionics Corporation Microstimulator-based electrochemotherapy methods and systems
US6890303B2 (en) 2001-05-31 2005-05-10 Matthew Joseph Fitz Implantable device for monitoring aneurysm sac parameters
AU2002326304A1 (en) * 2001-05-31 2002-12-16 Massachusetts Institute Of Technology Microchip devices with improved reservoir opening
US6767341B2 (en) * 2001-06-13 2004-07-27 Abbott Laboratories Microneedles for minimally invasive drug delivery
US6626940B2 (en) 2001-06-15 2003-09-30 Scimed Life Systems, Inc. Medical device activation system
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US7044911B2 (en) 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US7013177B1 (en) 2001-07-05 2006-03-14 Advanced Bionics Corporation Treatment of pain by brain stimulation
US7150737B2 (en) * 2001-07-13 2006-12-19 Sci/Med Life Systems, Inc. Methods and apparatuses for navigating the subarachnoid space
US7547321B2 (en) 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US6951536B2 (en) 2001-07-30 2005-10-04 Olympus Corporation Capsule-type medical device and medical system
US7208005B2 (en) 2001-08-06 2007-04-24 The Penn State Research Foundation Multifunctional tool and method for minimally invasive surgery
US7063714B2 (en) 2001-08-22 2006-06-20 Gore Enterprise Holdings, Inc. Apparatus and methods for treating stroke and controlling cerebral flow characteristics
US20060241717A1 (en) * 2001-08-30 2006-10-26 Whitehurst Todd K Treatment of movement disorders by extra dural motor cortex stimulation
ATE327798T1 (en) 2001-09-10 2006-06-15 Thermocore Medical Systems N V ARRANGEMENT FOR POSITIONING CATHETERS
US6764441B2 (en) 2001-09-17 2004-07-20 Case Western Reserve University Peristaltically self-propelled endoscopic device
US6860867B2 (en) 2001-09-20 2005-03-01 The Regents Of The University Of California Method of interventional surgery
AU2002337596A1 (en) 2001-09-27 2003-04-07 Galil Medical Ltd. Cryoplasty apparatus and method
US6770027B2 (en) 2001-10-05 2004-08-03 Scimed Life Systems, Inc. Robotic endoscope with wireless interface
US6849183B2 (en) 2002-08-13 2005-02-01 Transvivo, Inc. Method and apparatus for therapeutic apheresis
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
KR100417163B1 (en) 2001-11-12 2004-02-05 한국과학기술연구원 Micro capsule robot
US20050121411A1 (en) 2002-10-29 2005-06-09 Microfabrica Inc. Medical devices and EFAB methods and apparatus for producing them
US7498714B2 (en) 2003-09-24 2009-03-03 Microfabrica Inc. Multi-layer three-dimensional structures having features smaller than a minimum feature size associated with the formation of individual layers
US7372616B2 (en) 2001-12-06 2008-05-13 Microfabrica, Inc. Complex microdevices and apparatus and methods for fabricating such devices
WO2004027786A2 (en) 2002-09-20 2004-04-01 Enventure Global Technology Protective sleeve for expandable tubulars
US20030163177A1 (en) 2002-01-18 2003-08-28 Eggers Philip E. System method and apparatus for localized heating of tissue
US6855115B2 (en) 2002-01-22 2005-02-15 Cardiomems, Inc. Implantable wireless sensor for pressure measurement within the heart
US6828908B2 (en) 2002-02-06 2004-12-07 Ronald Scott Clark Locator system with an implanted transponder having an organically-rechargeable battery
IL154391A (en) 2002-02-11 2009-05-04 Given Imaging Ltd Self propelled device
US6939290B2 (en) 2002-02-11 2005-09-06 Given Imaging Ltd Self propelled device having a magnetohydrodynamic propulsion system
JP2005517422A (en) 2002-02-19 2005-06-16 シンセリカ・コーポレイション Alternative antibodies and their preparation and use
US7236821B2 (en) 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
JP4624678B2 (en) 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス,インコーポレイテッド Cross-linked bioactive hydrogel matrix
US20030171738A1 (en) * 2002-03-06 2003-09-11 Konieczynski David D. Convection-enhanced drug delivery device and method of use
US6889091B2 (en) 2002-03-06 2005-05-03 Medtronic, Inc. Method and apparatus for placing a coronary sinus/cardiac vein pacing lead using a multi-purpose side lumen
US20030216622A1 (en) 2002-04-25 2003-11-20 Gavriel Meron Device and method for orienting a device in vivo
GB2389791B (en) 2002-04-30 2006-12-13 Steven Gill Implantable drug delivery pump
US7368190B2 (en) 2002-05-02 2008-05-06 Abbott Diabetes Care Inc. Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
US6755802B2 (en) 2002-05-06 2004-06-29 Beckman Coulter, Inc. Whole blood sampling device
WO2003094795A1 (en) 2002-05-10 2003-11-20 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
WO2003097156A1 (en) 2002-05-16 2003-11-27 Scott Laborotories Inc. Kits of medical supplies for sedation and analgesia
US20030220556A1 (en) 2002-05-20 2003-11-27 Vespro Ltd. Method, system and device for tissue characterization
US7003352B1 (en) 2002-05-24 2006-02-21 Advanced Bionics Corporation Treatment of epilepsy by brain stimulation
US6833003B2 (en) 2002-06-24 2004-12-21 Cordis Neurovascular Expandable stent and delivery system
US7314484B2 (en) 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US6925357B2 (en) 2002-07-25 2005-08-02 Intouch Health, Inc. Medical tele-robotic system
EP1536731A2 (en) * 2002-08-01 2005-06-08 The Johns Hopkins University Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence
KR100482275B1 (en) 2002-08-09 2005-04-13 한국과학기술연구원 Micro capsule robot
WO2004014227A1 (en) * 2002-08-13 2004-02-19 Given Imaging Ltd. System for in vivo sampling and analysis
US6991617B2 (en) 2002-08-21 2006-01-31 Hektner Thomas R Vascular treatment method and device
DE10239743A1 (en) * 2002-08-29 2004-03-25 Rehau Ag + Co. Implantable brain parameter measurement device comprises a sensor unit with sensor mounted in a catheter that is inserted into the brain tissue and electronics mounted on a base plate and encapsulated between skull and tissue
US8449452B2 (en) 2002-09-30 2013-05-28 Given Imaging Ltd. In-vivo sensing system
US7794494B2 (en) 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices
EP1629341A4 (en) 2002-10-15 2008-10-15 Medtronic Inc Multi-modal operation of a medical device system
US6936003B2 (en) 2002-10-29 2005-08-30 Given Imaging Ltd In-vivo extendable element device and system, and method of use
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20040133147A1 (en) 2002-11-06 2004-07-08 Woo Sang Hoon Intestinal bypass device to treat obesity
US7039450B2 (en) 2002-11-15 2006-05-02 Biosense Webster, Inc. Telescoping catheter
US7697972B2 (en) 2002-11-19 2010-04-13 Medtronic Navigation, Inc. Navigation system for cardiac therapies
US6959215B2 (en) 2002-12-09 2005-10-25 Northstar Neuroscience, Inc. Methods for treating essential tremor
AU2003303387A1 (en) * 2002-12-23 2004-07-22 Medtronic, Inc. Multiple infusion section catheters, systems, and methods
US8246602B2 (en) * 2002-12-23 2012-08-21 Medtronic, Inc. Catheters with tracking elements and permeable membranes
US7037343B2 (en) 2002-12-23 2006-05-02 Python, Inc. Stomach prosthesis
AU2003288516A1 (en) 2002-12-26 2004-07-22 Given Imaging Ltd. Immobilizable in vivo sensing device
US20040230182A1 (en) * 2002-12-27 2004-11-18 Medtronic, Inc. Drug delivery through encapsulation
US7228162B2 (en) 2003-01-13 2007-06-05 Isense Corporation Analyte sensor
US20050058701A1 (en) 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
US20040267240A1 (en) 2003-01-29 2004-12-30 Yossi Gross Active drug delivery in the gastrointestinal tract
AU2003901345A0 (en) * 2003-03-21 2003-04-03 Ventracor Limited Improved cannula
US7245954B2 (en) 2003-03-27 2007-07-17 Given Imaging Ltd. Measuring a gradient in-vivo
US20040199246A1 (en) 2003-04-02 2004-10-07 Scimed Life Systems, Inc. Expandable stent
US20040199054A1 (en) 2003-04-03 2004-10-07 Wakefield Glenn Mark Magnetically propelled capsule endoscopy
US20050107870A1 (en) 2003-04-08 2005-05-19 Xingwu Wang Medical device with multiple coating layers
US20050278020A1 (en) 2003-04-08 2005-12-15 Xingwu Wang Medical device
US20050079132A1 (en) 2003-04-08 2005-04-14 Xingwu Wang Medical device with low magnetic susceptibility
US20050182482A1 (en) 2003-04-08 2005-08-18 Xingwu Wang MRI imageable medical device
US7383071B1 (en) 2003-04-25 2008-06-03 United States Of America As Represented By The Secretary Of The Navy Microsensor system and method for measuring data
US7297113B1 (en) 2003-04-25 2007-11-20 United States Of America As Represented By The Secretary Of The Navy Microsensor system and method for measuring data
EP1488735B1 (en) 2003-06-17 2007-06-13 Raymond Moser Instrumented retrievable implantable device
US20050004553A1 (en) * 2003-07-02 2005-01-06 Medtronic Ave, Inc. Sheath catheter having variable over-the-wire length and methods of use
US7042184B2 (en) 2003-07-08 2006-05-09 Board Of Regents Of The University Of Nebraska Microrobot for surgical applications
US7126303B2 (en) 2003-07-08 2006-10-24 Board Of Regents Of The University Of Nebraska Robot for surgical applications
US7066180B2 (en) 2003-07-09 2006-06-27 Airmatrix Technologies, Inc. Method and system for measuring airflow of nares
US7066879B2 (en) * 2003-07-15 2006-06-27 The Trustees Of Columbia University In The City Of New York Insertable device and system for minimal access procedure
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
US20050021023A1 (en) 2003-07-23 2005-01-27 Scimed Life Systems, Inc. System and method for electrically determining position and detachment of an implantable device
US20050027236A1 (en) * 2003-07-30 2005-02-03 Medtronic Ave, Inc. Aspiration catheter having a variable over-the-wire length and methods of use
US20050069925A1 (en) 2003-08-15 2005-03-31 Russell Ford Microprocessors, devices, and methods for use in monitoring of physiological analytes
CN101094622A (en) 2003-09-18 2007-12-26 先进生物假体表面有限公司 Medical devices having mems functionality and methods of making same
US20050065592A1 (en) 2003-09-23 2005-03-24 Asher Holzer System and method of aneurism monitoring and treatment
US7002331B2 (en) 2004-01-13 2006-02-21 Delta Electronics, Inc. Modular power supply system including a power status signal generator to perform fast sag detection to input peak voltage
WO2005067817A1 (en) 2004-01-13 2005-07-28 Remon Medical Technologies Ltd Devices for fixing a sensor in a body lumen
ITPI20040008A1 (en) 2004-02-17 2004-05-17 Dino Accoto ROBOTIC CAPSULE FOR INTRA-BODY BIOMEDICAL APPLICATIONS
US8915957B2 (en) 2004-03-11 2014-12-23 Alcatel Lucent Drug delivery stent
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US8163269B2 (en) 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
US20050234440A1 (en) 2004-04-19 2005-10-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System with a sensor for perfusion management
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US20070010868A1 (en) 2004-04-19 2007-01-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Lumenally-active device
US8000784B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
WO2005102458A2 (en) 2004-04-19 2005-11-03 The Board Of Trustees, The Leland Stanford Junior University Airway implant devices and methods of use
US7125382B2 (en) 2004-05-20 2006-10-24 Digital Angel Corporation Embedded bio-sensor system
US20050277839A1 (en) 2004-06-10 2005-12-15 Honeywell International, Inc. Wireless flow measurement in arterial stent
EP1618831A3 (en) 2004-06-29 2006-04-19 Nippon Cable System Inc. A moving device in pipe lines
US7857369B2 (en) 2004-06-30 2010-12-28 Case Western Reserve University Biologically inspired gripping device
US7729761B2 (en) 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US7970631B2 (en) 2004-08-31 2011-06-28 Ethicon Endo-Surgery, Inc. Medical effector system
KR100702155B1 (en) 2005-05-12 2007-04-02 한국과학기술연구원 Capsule type micro-robot moving system
US7729773B2 (en) * 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
EP2030643A1 (en) * 2006-04-06 2009-03-04 Medtronic, Inc. Systems and methods for identifying catheter malfunctions using pressure sensing
US7744542B2 (en) 2006-04-20 2010-06-29 Cardiac Pacemakers, Inc. Implanted air passage sensors
US7713196B2 (en) 2007-03-09 2010-05-11 Nellcor Puritan Bennett Llc Method for evaluating skin hydration and fluid compartmentalization
EP2163206B1 (en) 2008-09-16 2012-12-12 Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna Surgical clip delivering wireless capsule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295990B1 (en) * 1998-02-03 2001-10-02 Salient Interventional Systems, Inc. Methods and systems for treating ischemia

Also Published As

Publication number Publication date
WO2005102408A3 (en) 2007-05-10
US7871402B2 (en) 2011-01-18
US7850676B2 (en) 2010-12-14
US20080039783A1 (en) 2008-02-14
US20080039779A1 (en) 2008-02-14
US20110208020A1 (en) 2011-08-25
US20050234398A1 (en) 2005-10-20
US7867217B2 (en) 2011-01-11
US20110282485A1 (en) 2011-11-17
US8323263B2 (en) 2012-12-04

Similar Documents

Publication Publication Date Title
US8361014B2 (en) Telescoping perfusion management system
WO2005102408A2 (en) A telescoping perfusion management system
US8361056B2 (en) System with a reservoir for perfusion management
US20050234440A1 (en) System with a sensor for perfusion management
US6936003B2 (en) In-vivo extendable element device and system, and method of use
JP2022130442A (en) Medical device having visible puncture apparatus
US8394034B2 (en) Device, system and method for in-vivo sampling
US20040111011A1 (en) Capsule medical apparatus and control method for capsule medical apparatus
JP2010531718A (en) Improved catheter
JP2013516291A (en) Improved catheter
US20210267438A1 (en) Miniaturized intra-body controllable medical device employing machine learning and artificial intelligence
EP3053617B1 (en) Pressure-driven irrigation pump
US20200405132A1 (en) Ingestible device with manipulation capabilities
CN116867442A (en) Conveying and collecting system comprising micro-robots

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase